Surrey researchers Sign in
Pre-clinical development of the anti-tumour agent CB 7646, bis N-(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamol
Journal article

Pre-clinical development of the anti-tumour agent CB 7646, bis N-(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamol

HM Coley, M Jarman, N Brooks, T Kubota, PM Goddard, M Jones, N Lee, MD Owens, GW Halbert and IR Judson
INTERNATIONAL JOURNAL OF CANCER, Vol.68(3), pp.356-363
04/11/1996

Abstract

Science & Technology Life Sciences & Biomedicine Oncology ONCOLOGY OVARIAN-CARCINOMA XENOGRAFTS PHASE-I HEXAMETHYLMELAMINE CANCER PHARMACOKINETICS FORMULATION TRIAL DRUG
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VR17600014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

Details

Usage Policy